China News Agency, Berlin, December 21 (Reporter Peng Dawei) The German Federal Government stated on the 21st that the new crown vaccine developed by the German BioNTech and Pfizer in the United States had been recommended by the European Medicines Agency on the same day. It was listed and approved by the European Commission on the same day.
Germany plans to launch this vaccine in China on the 27th of this month.
The German Federal Government announced the news in a press release that day.
The BNT162b2 new crown vaccine jointly developed by the two companies mentioned above uses messenger ribonucleic acid (mRNA) technology.
The results of Phase III clinical trials show that this vaccine is 95% effective.
Previously, the United States and the United Kingdom have begun to receive this vaccine.
Emer Cooke, director of the European Medicines Agency, said that although the speed of the vaccine development has been increased to the fastest possible extent, the safety of the vaccine is always the highest priority.
She said that this vaccine meets the EU's strict requirements on effectiveness and safety.
The EU official recommends that this vaccine be used only for people over 16 years of age.
After being approved at the EU level, the German vaccine regulatory agency Paul Ehrlich Institute will be responsible for approving the release of this vaccine in Germany.
According to the vaccination plan established by the German health department, the vaccine will first be transported to 27 distribution centers, and then transferred to each federal state, and then distributed to the vaccination centers established within its territory.
The German government said that according to the current situation, it will start vaccination on the 27th of this month as planned.
Germany has announced the priority of vaccination. The residents and staff of nursing homes, elderly people over 80, first-aid and emergency medical staff, and intensive care unit medical staff will be the first to receive vaccination opportunities.
German President Steinmeier also inspected a remodeled vaccination center in an exhibition hall in Berlin on the 21st.
Albrecht Bromé, who is in charge of the construction of the Berlin Vaccination Center, recently introduced to a reporter from China News Agency that the Vaccination Center will not be open to the public to vaccinate freely at the beginning of its opening. Some people who need to be vaccinated issue "vaccination invitations", and only those who are invited can be vaccinated.
(Finish)